- Home
- PDS vs NBTX Comparison
PDS vs NBTX Comparison
Compare PDS & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDS
- NBTX
- Stock Information
- Founded
- PDS 1951
- NBTX 2003
- Country
- PDS Canada
- NBTX France
- Employees
- PDS N/A
- NBTX N/A
- Industry
- PDS
- NBTX Biotechnology: Pharmaceutical Preparations
- Sector
- PDS
- NBTX Health Care
- Exchange
- PDS Nasdaq
- NBTX Nasdaq
- Market Cap
- PDS 764.8M
- NBTX 868.8M
- IPO Year
- PDS N/A
- NBTX 2020
- Fundamental
- Price
- PDS $56.93
- NBTX $27.46
- Analyst Decision
- PDS Buy
- NBTX Strong Buy
- Analyst Count
- PDS 2
- NBTX 1
- Target Price
- PDS $87.00
- NBTX $8.00
- AVG Volume (30 Days)
- PDS 76.2K
- NBTX 130.5K
- Earning Date
- PDS 10-22-2025
- NBTX 09-30-2025
- Dividend Yield
- PDS N/A
- NBTX N/A
- EPS Growth
- PDS N/A
- NBTX N/A
- EPS
- PDS 5.22
- NBTX N/A
- Revenue
- PDS $1,355,177,217.00
- NBTX $11,930,711.00
- Revenue This Year
- PDS N/A
- NBTX N/A
- Revenue Next Year
- PDS $1.64
- NBTX $74.67
- P/E Ratio
- PDS $10.88
- NBTX N/A
- Revenue Growth
- PDS N/A
- NBTX N/A
- 52 Week Low
- PDS $36.20
- NBTX $2.76
- 52 Week High
- PDS $67.35
- NBTX $27.77
- Technical
- Relative Strength Index (RSI)
- PDS 53.83
- NBTX 80.37
- Support Level
- PDS $57.10
- NBTX $20.15
- Resistance Level
- PDS $59.11
- NBTX $22.64
- Average True Range (ATR)
- PDS 1.31
- NBTX 1.60
- MACD
- PDS -0.18
- NBTX 0.86
- Stochastic Oscillator
- PDS 49.78
- NBTX 99.13
About PDS Precision Drilling Corporation
Precision Drilling Corp is a provider of contract drilling and completion and production services to oil and natural gas exploration and production companies in Canada, the United States, and certain international locations. Contract Drilling Services include drilling rigs, procurement and distribution of oilfield supplies, and the manufacture, sale and repair of drilling equipment. Completion and Production Services include service rigs, oilfield equipment rental, and camp and catering services.
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.